FF:0000350: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{F5terms | {{F5terms | ||
| | |alt_id= | ||
|comment= | |comment= | ||
|created_by=tmeehan | |created_by=tmeehan | ||
| | |def= | ||
|derives_from= | |derives_from= | ||
|develops_from= | |develops_from= | ||
|disjoint_from= | |||
|has_quality= | |has_quality= | ||
|id=FF:0000350 | |||
|is_a=FF:0000001 | |||
|is_obsolete= | |||
|located_in= | |located_in= | ||
|name=experimentally modified sample | |||
|namespace=FANTOM5 | |||
|obo_creation_date=2011-04-29T10:41:03Z | |||
|part_of= | |part_of= | ||
|preceded_by= | |||
|property_value= | |property_value= | ||
| | |subset= | ||
| | |synonym= | ||
|union_of= | |||
|xref= | |||
}} | }} | ||
Latest revision as of 10:39, 12 September 2014
outline
- id: FF:0000350
- name: experimentally modified sample
- namespace: FANTOM5
- created_by: tmeehan
- creation_date: 29 April 2011 10:41:03
- CAGEd oPOSSUM: NA
Ontology association
Parents
| is_a: | FF:0000001(sample) |
|---|
Children
| is a: | FF:0000408 (cellular fractionation sample),FF:0000410 (human Lymphatic Endothelial cells 0min after VEGFC treatment sample),FF:0000411 (human Lymphatic Endothelial cells 15min after VEGFC treatment sample),FF:0000412 (human Lymphatic Endothelial cells 30min after VEGFC treatment sample),FF:0000413 (human Lymphatic Endothelial cells 45min after VEGFC treatment sample),FF:0000414 (human Lymphatic Endothelial cells 1hr after VEGFC treatment sample),FF:0000415 (human Lymphatic Endothelial cells 80min after VEGFC treatment sample),FF:0000416 (human Lymphatic Endothelial cells 100min after VEGFC treatment sample),FF:0000417 (human Lymphatic Endothelial cells 2h after VEGFC treatment sample),FF:0000418 (human Lymphatic Endothelial cells 2.5h after VEGFC treatment sample),FF:0000419 (human Lymphatic Endothelial cells 3h after VEGFC treatment sample),FF:0000420 (human Lymphatic Endothelial cells 3.5h after VEGFC treatment sample),FF:0000421 (human Lymphatic Endothelial cells 4h after VEGFC treatment sample),FF:0000422 (human Lymphatic Endothelial cells 5h after VEGFC treatment sample),FF:0000423 (human Lymphatic Endothelial cells 6h after VEGFC treatment sample),FF:0000424 (human Lymphatic Endothelial cells 7h after VEGFC treatment sample),FF:0000425 (human Lymphatic Endothelial cells 8h after VEGFC treatment sample),FF:0000426 (human MCF7 breast cancer cell line 0min after EGF1 treatment sample),FF:0000427 (human MCF7 breast cancer cell line 15min after EGF1 treatment sample),FF:0000428 (human MCF7 breast cancer cell line 30min after EGF1 treatment sample),FF:0000429 (human MCF7 breast cancer cell line 45min after EGF1 treatment sample),FF:0000430 (human MCF7 breast cancer cell line 1hr after EGF1 treatment sample),FF:0000431 (human MCF7 breast cancer cell line 80min after EGF1 treatment sample),FF:0000432 (human MCF7 breast cancer cell line 100min after EGF1 treatment sample),FF:0000433 (human MCF7 breast cancer cell line 2h after EGF1 treatment sample),FF:0000434 (human MCF7 breast cancer cell line 2.5h after EGF1 treatment sample),FF:0000435 (human MCF7 breast cancer cell line 3h after EGF1 treatment sample),FF:0000436 (human MCF7 breast cancer cell line 3.5h after EGF1 treatment sample),FF:0000437 (human MCF7 breast cancer cell line 4h after EGF1 treatment sample),FF:0000438 (human MCF7 breast cancer cell line 5h after EGF1 treatment sample),FF:0000439 (human MCF7 breast cancer cell line 6h after EGF1 treatment sample),FF:0000440 (human MCF7 breast cancer cell line 7h after EGF1 treatment sample),FF:0000441 (human MCF7 breast cancer cell line 8h after EGF1 treatment sample),FF:0000442 (MCF7 breast cancer cell line 0min after HRG treatment),FF:0000443 (human MCF7 breast cancer cell line 15min after HRG treatment sample),FF:0000444 (human MCF7 breast cancer cell line 30min after HRG treatment sample),FF:0000445 (human MCF7 breast cancer cell line 45min after HRG treatment sample),FF:0000446 (human MCF7 breast cancer cell line 1hr after HRG treatment sample),FF:0000447 (human MCF7 breast cancer cell line 80min after HRG treatment sample),FF:0000448 (human MCF7 breast cancer cell line 100min after HRG treatment sample),FF:0000449 (human MCF7 breast cancer cell line 2h after HRG treatment sample),FF:0000450 (human MCF7 breast cancer cell line 2.5h after HRG treatment sample),FF:0000451 (human MCF7 breast cancer cell line 3h after HRG treatment sample),FF:0000452 (human MCF7 breast cancer cell line 3.5h after HRG treatment sample),FF:0000453 (human MCF7 breast cancer cell line 4h after HRG treatment sample),FF:0000454 (human MCF7 breast cancer cell line 5h after HRG treatment sample),FF:0000455 (human MCF7 breast cancer cell line 6h after HRG treatment sample),FF:0000456 (human MCF7 breast cancer cell line 7h after HRG treatment sample),FF:0000457 (human MCF7 breast cancer cell line 8h after HRG treatment sample),FF:0000458 (mouse ST2 Mesenchymal stem cells, cells 15 min after adipogenic induction sample)... further results |
|---|
FF Samples
Human
- 11843-124H7 (serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1)
- 12680-135B7
- 12681-135B8
- 12682-135B9
- 12683-135C1
- 12684-135C2
- 12685-135C3
- 12686-135C4
- 12687-135C5
- 12688-135C6
- 12689-135C7
- 12690-135C8
- 12691-135C9
- 12692-135D1
- 12693-135D2
- 12694-135D3
- 12695-135D4
- 12696-135D5
- 12697-135D6 (Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17))
- 12778-136D6
- 12779-136D7
- 12780-136D8
- 12781-136D9
- 12782-136E1
- 12783-136E2
- 12784-136E3
- 12785-136E4
- 12786-136E5
- 12787-136E6
- 12788-136E7
- 12789-136E8
- 12790-136E9
- 12791-136F1
- 12792-136F2
- 12793-136F3
- 12794-136F4
- 12795-136F5 (Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17))
- 12876-137F5
- 12877-137F6
- 12878-137F7
- 12879-137F8
- 12880-137F9
- 12881-137G1
- 12882-137G2
- 12883-137G3
- 12884-137G4
- 12885-137G5
- 12886-137G6
- 12887-137G7
- 12888-137G8
